Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas: Its Histopathologic Difference Between 2 Major Types
- 1 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Surgical Pathology
- Vol. 30 (12) , 1561-1569
- https://doi.org/10.1097/01.pas.0000213305.98187.d4
Abstract
Intraductal papillary mucinous neoplasm (IPMN) is a unique pancreatic neoplasm developing in the ductal system. Two major histologic subtypes have been reported, that is the gastric type and the intestinal type. However, their histopathologic features, especially those of the gastric type, have not been fully described. To evaluate the features of these two types and refine their differences, we analyzed 80 IPMNs including 50 cases of the gastric type and 30 cases of the intestinal type with mucin immunohistochemistry. By defining a main duct-type lesion as predominantly involving the main pancreatic duct with or without branch ducts, and a branch duct-type lesion as exclusively centered on branch ducts or consisting of a collection of small cystic lesions, gastric-type IPMNs were mostly branch duct-type lesions (98%), whereas the intestinal-type IPMNs were usually main duct type (73%). The histologic grade of the intestinal type was generally higher than that of the gastric type. The intestinal type was also characterized by frequent intraluminal nodular growth, and severe atrophy and fibrosis of the surrounding parenchyma with mucous lake formation. In contrast, pyloric glandlike structures at the base of the papillae and pancreatic intraepithelial neoplasia (PanIN)-like complexes were more frequently observed in the gastric type. A significant difference was observed between the gastric type and the intestinal type with regard to all the above features (P<0.05). Seven cases (23%) of the intestinal type were associated with an invasive adenocarcinoma (6 mucinous and 1 ductal), versus only 1 case (2%) of the gastric type (invasive ductal carcinoma). All cases of both gastric and intestinal types expressed MUC5AC; however, high immunolabeling scores for MUC2 were mostly observed in the intestinal type (P<0.05). In conclusion, gastric and intestinal types of IPMNs have distinct histopathologic features and mucin profiles, suggesting that they may follow different biologic pathways.Keywords
This publication has 41 references indexed in Scilit:
- Pancreatic Intraepithelial Neoplasia in Association With Intraductal Papillary Mucinous Neoplasms of the PancreasThe American Journal of Surgical Pathology, 2004
- Pathologically and Biologically Distinct Types of Epithelium in Intraductal Papillary Mucinous NeoplasmsThe American Journal of Surgical Pathology, 2004
- The Dichotomy in the Preinvasive Neoplasia to Invasive Carcinoma Sequence in the Pancreas: Differential Expression of MUC1 and MUC2 Supports the Existence of Two Separate Pathways of CarcinogenesisLaboratory Investigation, 2002
- Aberrant p16INK4A and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinomaGut, 2002
- Aberrant Methylation of Preproenkephalin and p16 Genes in Pancreatic Intraepithelial Neoplasia and Pancreatic Ductal AdenocarcinomaThe American Journal of Pathology, 2002
- Intraductal papillary‐mucinous neoplasms of the pancreasCancer, 2001
- Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal diseaseGut, 2000
- Progression of atypical ductal hyperplasia/carcinoma in situ of the pancreas to invasive adenocarcinomaAnnals of Diagnostic Pathology, 1998
- Progression of Pancreatic Intraductal Neoplasias to Infiltrating Adenocarcinoma of the PancreasThe American Journal of Surgical Pathology, 1998
- Intraductal papillary tumors and mucinous cystic tumors of the pancreas: Clinicopathologic study of 38 casesHuman Pathology, 1997